Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
THAMEUS from Liège, company number BE1008238883, closed financial year 2025 with a result of € -120,416 after tax. For that financial year THAMEUS recorded a gross margin of € -119,888 and equity of € 419,327. Compared with financial year 2024, the result moved from € -120,257 to € -120,416. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 419,327
▲ 100% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -120,416
Profit after tax over the fiscal year.
€ 451,599
▲ 99% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -240,673.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 81,108
▲ 153% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,224
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -118,284 | € -119,888 | ▼ € 1,604 |
| Profit after taxes | € -120,257 | € -120,416 | |
| Equity | € 209,743 | € 419,327 | ▲ 100% |
| Total debts | € 31,998 | € 83,332 | ▲ 160% |
| Cash | € 226,938 | € 451,599 | ▲ 99% |
| Retained profit | € -120,257 | € -240,673 | ▼ € 120,416 |
| Balance sheet total | € 241,742 | € 502,659 | ▲ 108% |
Key figures of THAMEUS, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to THAMEUS?
What happened at THAMEUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- NOSHAQ PARTNERS SRL stepped down as director. NBB
- Centre Hospitalier Universitaire de Liège (CHU) ASBL stepped down as director. NBB
- Didier Allaer stepped down as director. NBB
- Laurent Servais stepped down as director. NBB
- BMRF Consult SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 120,416. Source: NBB ↗
- BMRF Consult SRL became a director. NBB
- New establishment in Liège. KBO
In short
From € 120,257 loss in 2024 to € 120,416 loss in 2025.
A new publication or filing at THAMEUS? We notify you, reason included.
Follow THAMEUSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NOSHAQ VENTURE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
THAMEUSThe shares are held by NOSHAQ VENTURE (29.4%).
Directors
According to the 2025 annual accounts
Director · represented by François Boemer
since 2026 · until 2030
Director · represented by Eric BRANDT
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
since 2024 · until 2030
Centre Hospitalier Universitaire de Liège (CHU) ASBL
Director · represented by Marc DE PAOLI
Also active at: Santhea, Bridge2Health
since 2024 · until 2030
since 2024 · until 2030
Laurent Servais
Director
since 2024 · until 2030
Shareholders
29.4%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue de l'Hôpital 11 box SPS, +3
4000 Liège
Avenue de l'Hôpital 11 box SPS+3
4000 Liège
Active since 10 April 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1008.238.883
- VAT number
- BE 1008.238.883
- Registered office
- Avenue de l'Hôpital 11 bus SPS, +3, 4000 Liège
- Names & denominations
- THAMEUS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 April 2024
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Vervaardiging van overige farmaceutische producten